» Articles » PMID: 38628040

Experiences of Predictive Genetic Testing in Inherited Motor Neuron Disease: Findings from a Qualitative Interview Study

Overview
Journal J Genet Couns
Publisher Wiley
Specialty Genetics
Date 2024 Apr 17
PMID 38628040
Authors
Affiliations
Soon will be listed here.
Abstract

Predictive genetic testing is increasingly available for individuals with a heightened risk of motor neuron disease (MND). However, little is known about how they decide whether or not to get tested, and how they experience this process. This paper reports findings from a constructivist grounded theory-informed interview study with 24 family members of people with identified or suspected inherited MND (iMND). Fourteen did not know their genetic status, and nine had decided to have predictive testing, of whom six tested positive for the pathogenic gene variant identified in their family and three tested negative. One additional person was identified as negative through a parent's negative result. This paper explores the diverse ways people approached testing, and the many factors and motivations involved, based on personal attitudes and goals, experiences of living with genetic risk, and wider family considerations and circumstances. Results were met with a range of emotions; whatever the outcome, the news disrupted each person's view of the future, and they adapted in their own way and time. Support after results was variable and a perceived lack of support impacted coping and the ability to move forwards. This paper situates findings against literature on other genetic conditions, highlighting experiences as grounded in the unique characteristics of iMND. Thus, it emphasizes the need for disease-specific guidelines and support structures around predictive genetic testing in this context. Understanding people's experiences and responding to these needs is particularly timely given the uptake of testing amongst this group is anticipated to rise with increasing access to genetic testing for people with MND, and gene-specific clinical trials.

Citing Articles

Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation.

Abbott M, Ryan M, Hernandez R, Heidenreich S, Miedzybrodzka Z Appl Health Econ Health Policy. 2025; .

PMID: 40082384 DOI: 10.1007/s40258-025-00948-x.


Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members.

Howard J, Chaouch A, Douglas A, MacLeod R, Roggenbuck J, McNeill A Eur J Hum Genet. 2024; 33(1):7-13.

PMID: 39501102 PMC: 11711763. DOI: 10.1038/s41431-024-01718-4.


Experiences of predictive genetic testing in inherited motor neuron disease: Findings from a qualitative interview study.

Howard J, Forrest Keenan K, Mazanderani F, Turner M, Locock L J Genet Couns. 2024; 34(1):e1904.

PMID: 38628040 PMC: 11735176. DOI: 10.1002/jgc4.1904.

References
1.
Konrad M . Predictive genetic testing and the making of the pre-symptomatic person: Prognostic moralities amongst Huntington's-affected families. Anthropol Med. 2016; 10(1):23-49. DOI: 10.1080/13648470301269. View

2.
Goutman S, Hardiman O, Al-Chalabi A, Chio A, Savelieff M, Kiernan M . Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022; 21(5):465-479. PMC: 9513754. DOI: 10.1016/S1474-4422(21)00414-2. View

3.
Roggenbuck J, Quick A, Kolb S . Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians. Genet Med. 2016; 19(3):267-274. DOI: 10.1038/gim.2016.107. View

4.
Etchegary H . 'I put it on the back burner most days': Living with chronic risk. Health (London). 2010; 15(6):633-49. DOI: 10.1177/1363459310364162. View

5.
Richards F . Couples' experiences of predictive testing and living with the risk or reality of Huntington disease: a qualitative study. Am J Med Genet A. 2004; 126A(2):170-82. DOI: 10.1002/ajmg.a.20583. View